 The FDA has lifted the clinical hold on LogicBio Therapeutics Incs NASDAQ: LOGC LB-001 Investigational New Drug Application IND to resume patient enrollment in Phase 12 SUNRISE trial in pediatric methylmalonic acidemia patients. Methylmalonic acidemia is an. 